UNHNYSEHospital & Medical Service PlansFiscal year ends December 31
UNITEDHEALTH GROUP INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$406.88+5.45 (+1.36%)
Close on Oct 19, 2026
- Market cap
- $368.63B
- P/E (TTM)
- 26.2
- Dividend yield
- 2.15%
UNITEDHEALTH GROUP INC revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UnitedHealthcare | $86.02B | $86.27B | $87.11B | $87.07B | $86.10B | $84.62B | $74.13B | $74.85B | $73.87B | $75.36B | $70.81B | $69.85B | 76.8% | -0.1% |
| Optum | $65.66B | $63.75B | $70.33B | $69.18B | $67.23B | $63.89B | $65.10B | $63.93B | $62.88B | $61.05B | $59.50B | $56.74B | 58.6% | -2.3% |
| Optum Rx | $38.29B | $35.74B | – | $39.68B | $38.46B | $35.13B | – | $34.21B | $32.42B | $30.84B | – | $28.86B | 34.2% | -0.4% |
| Optum Health | $23.47B | $24.11B | – | $25.90B | $24.73B | $24.84B | – | $25.92B | $27.05B | $26.73B | – | $23.86B | 21.0% | -5.1% |
| Optum Insight | $5.40B | $5.13B | – | $4.92B | $5.23B | $5.03B | – | $4.93B | $4.54B | $4.50B | – | $4.98B | 4.8% | +3.2% |
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Optum | $4.05B | $3.30B | $61.00M | $2.51B | $3.08B | $3.89B | $4.80B | $4.50B | $3.87B | $3.54B | $4.57B | $3.93B | +31.7% |
| UnitedHealthcare | $3.94B | $5.69B | $319.00M | $1.81B | $2.08B | $5.23B | $2.97B | $4.21B | $4.00B | $4.40B | $3.12B | $4.59B | +90.0% |
| Optum Rx | $1.49B | $1.19B | – | $1.55B | $1.44B | $1.32B | – | $1.54B | $1.41B | $1.15B | – | $1.26B | +3.4% |
| Optum Insight | $1.37B | $963.00M | – | $706.00M | $1.21B | $1.16B | – | $791.00M | $546.00M | $490.00M | – | $1.11B | +13.6% |
| Optum Health | $1.19B | $1.14B | – | $255.00M | $429.00M | $1.41B | – | $2.16B | $1.92B | $1.90B | – | $1.57B | +177.4% |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Products | $13.84B | $13.25B | $13.48B | $13.30B | $13.56B | $13.04B | $13.48B | $12.63B | $12.21B | $11.91B | $11.31B | $10.35B | 12.3% | +2.0% |
| Services | $10.02B | $9.78B | $10.27B | $9.75B | $9.04B | $8.97B | $9.30B | $9.10B | $8.75B | $8.89B | $8.71B | $8.67B | 8.9% | +10.8% |
By region
From the segment and revenue-disaggregation notes of Unitedhealth's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.